The lymphatic system serves a major bodily function, which is to provide a system to return fluid and plasma protein from the tissues, restoring them to blood circulation. Thus, the lymphatic system plays a pivotal role in the overall homeostasis of body fluids and plasma protein [1] . The functions carried out depend on active and passive driving mechanisms and the rate of lymph production in organs and tissues. The active driving mechanisms are due to the intrinsic heart-like contractility of the lymph vessels [2] [3] [4] .
Little information exists, however, regarding the potential effects of flow on lymphatic endothelial cells in the pressurized thoracic ducts. Thus we have attempted to determine whether the stimulation of flow can produce and release endothelium-derived relaxing factors from lymphatic endothelial cells in pressurized canine thoracic ducts, and then to evaluate the biological properties of flow-mediated relaxing factor(s) released from the lymphatic endothelial cells by using classical cascade bioassay preparations of isolated coronary arterial rings without intact endothelium.
MATERIALS AND METHODS
Tissue preparation. Twenty-two adult mongrel dogs of both sexes, weighing 8.0-15.0 kg were anesthetized with pentobarbital sodium (25 mg/kg I.V.) and exsanguinated from the femoral vein. Before exsanguination, heparin (500 U/kg) was administrated intravenously in all animals. The left circumflex coronary arteries and thoracic ducts were rapidly dissected out and cleaned of surrounding tissues. The arteries and lymph vessels were maintained in Krebs-bicarbonate solution of the following composition (mM): 120.0 NaCl, 5.9 KCl, 25.0 NaHCO 3 , 1.2 NaH 2 PO 4 , 2.5 CaCl 2 , 1.2 MgCl 2 , and 5.5 glucose. The solution was aerated with 95% O 2 and 5% CO 2 to give a pH of 7.4. The other tissues from these animals were used in other studies. All animals were obtained from a licensed source (Nihon-Nousan-Kougyou, Yokohama, Japan). The experimental protocols were approved by the Animal Ethics Committee, Shinshu University School of Medicine, in accordance with the principles and guidelines of the Physiological Society of Japan for Animal Care.
Bioassay preparation. The technique using a conventional bioassay cascade, which was described by Fukaya et al. [12] , was used with modifications in the presents. Cylindrical segments isolated from canine thoracic ducts were perfused at a constant flow rate ranging from 0.5 to 2.0 ml/min. Endothelium-dependent NO activity in the perfusion effluent through the lymphatic segments was measured by a relaxation of the endothelium denuded arterial bioassay rings. After the adherent loose connective and adipose tissues of the thoracic ducts were removed, cylindrical segments (40 mm long) were cut from the isolated truncal lymph vessels. Care was taken not to damage the lymphatic endothelial cells. In some lymph vessel segments, they were everted and mechanically removed by rubbing the internal surface with Krebssoaked filter paper (Toyo Advantec, Tokyo, Japan). The presence or absence of lymphatic endothelial cells was confirmed histologically by silver staining [13, 14] . The segments were cannulated at both ends and placed into an organ bath maintained at 37°C and filled with 10 ml of aerated (95% O 2 -5% CO 2 ) Krebsbicarbonate solution. To change the flow rate on the lymphatic endothelial cells, the Krebs-bicarbonate solution (37°C) was intraluminally perfused through the cannulated lymph vessel segment by using an infusion pump. To maintain a patent cross section in the lymphatic segment, a constant transmural pressure (ϳ5 cmH 2 O) was kept in all lymphatic segments throughout the experiments. The transluminal pressure is known to be a physiological range of canine thoracic duct [7, 15] . The flow rate through the pressurized thoracic ducts was continuously monitored by means of a domestically made drop counter placed at the end of the perfusion system. The drop counter was calibrated against a direct measurement of volume by using a measuring cylinder.
It is well known that the arterial ring isolated from canine coronary artery is one of the best bioassay preparations for evaluating endogenous nitric oxidemediated vasodilation [12] . Therefore a ring of coronary artery (4 mm wide), from which the endothelium had been removed by rubbing the internal surface with Krebs-soaked filter paper, was suspended directly below the organ bath by two tungsten steel wires passed through its lumen. The absence of endothelial cells in some arterial bioassay rings was confirmed histologically by silver staining [13, 14] . The mechanical rubbing also caused no significant effect on the high-potassium-mediated contractions of the arterial bioassay rings. One wire was connected to an isometric force transducer (Shinko Tsushin UL-10, Tokyo, Japan) and another was anchored. The circumferential isometric tension detected by the transducer was amplified and recorded on a direct-writing oscillograph (Sanei Sokki 8K, Tokyo, Japan). The zero tension level in each arterial bioassay ring was determined to be the point just before the ring was subjected to any stretch. From the zero tension level, the resting tension of the arterial bioassay rings was set and maintained at 2.0 g; this tension has been found to be optimal for obtaining a maximal contraction response to a high-potassium (80 mM K ϩ ) Krebs-bicarbonate solution [12] . The high-potassium solution was prepared by replacing NaCl with equimolar amounts of KCl. The bioassay assembly could be moved freely below the organ bath, allowing the bioassay arterial ring to be superfused with efferent from either the pressurized lymph vessel segment or a stainless steel tube. The stainless steel tube was substituted in place of the pressurized lymph vessel segment to evaluate the tran-sient time of active endothelium-derived relaxing factor(s) reaching the bioassay arterial rings.
The bioassay arterial ring was superfused at a constant flow rate (3 ml/min) with 37°C, pH 7.4, Krebsbicarbonate solution containing no vasoconstrictive agent through a polyethylene tubing (direct superfusion) for 60 min to maintain an equilibrium of mechanical activity of the arterial smooth muscles. The transient time of effluent flow between the pressurized lymphatic segment and the bioassay arterial ring was ϳ1 s. Drugs were infused either above the pressurized lymph vessel segment (site 1; allowing contact with intact endothelium) or above the polyethylene tubing (site 2; avoiding contact with intact endothelium).
Experimental protocols.
Protocol 1. The arterial bioassay ring was superfused directly at a constant flow rate of 3 ml/min with Krebs-bicarbonate solution containing prostaglandin F 2␣ (PG F 2␣ , 5ϫ10
Ϫ5 M) or a thromboxane A 2 analog, U46619 (10 Ϫ8 M), through the polyethylene tubing. This produced a tonic contraction of the bioassay arterial rings that was ϳ60% of the contraction produced by 80 mM K ϩ in each ring. After the agonist-induced contraction had reached a steady state, the effluent of Krebs-bicarbonate solution containing 5ϫ10 Ϫ5 M PG F 2␣ or 10 Ϫ8 M U46619 was superfused for 2 min at three flow rates (0.5, 1.0, and 2.0 ml/min) through the pressurized lymph vessel segments or through the stainless steel tube over the arterial bioassay ring. After the flow-induced response of each arterial bioassay ring was recorded, Krebs-bicarbonate solution containing 5ϫ10 Ϫ5 M PG F 2␣ and 10 Ϫ5 M acetylcholine (ACh) or 10 Ϫ8 M U46619 and 10 Ϫ5 M ACh was perfused from site 1 at a flow rate of 0.5 ml/min. At the end of each series of experiments, Krebs-bicarbonate solution containing 5ϫ10 Ϫ5 M PG F 2␣ and sodium nitroprusside (SNP, 10 Ϫ5 M) or 10 Ϫ8 M U46619 and 10 Ϫ5 M SNP was superfused directly (site 2) over the arterial bioassay ring to obtain maximal relaxation.
Protocol 2. The flow (1.0 ml/min) only-and the flow (0.5 ml/min)ϩACh (10 Ϫ5 M)-induced responses of the bioassay arterial rings without intact endothelium were evaluated before and more than 20 min after perfusion with Krebs-bicarbonate solution containing PG F 2␣ (5ϫ10 Ϫ5 M PG F 2␣ and 10 Ϫ5 M SNP was superfused over the arterial bioassay ring in the same manner as the one described in protocols 1 and 2.
Drugs. The following agents were used: ACh chloride (Daiichi Seiyaku, Tokyo, Japan); PG F 2␣ (Ono Yakuhin, Osaka, Japan); SNP (Merck, Germany); U46619, L-NAME hydrochloride, L-arginine hydrochloride, and indomethacin (Sigma, USA). All concentrations are expressed as a molar concentration of the solution superfusing the arterial bioassay rings.
Calculations and statistical analyses. Each experimental group consisted of 3-6 thoracic ducts taken from different dogs. Experimental values were expressed as meanϮstandard error of the mean (SEM). Statistical analyses were made with either Fisher's PLSD test after a one-way analysis of variance (ANOVA) or Student's t-test for paired and unpaired observations. The differences were considered to be statistically significant when pϽ0.05.
With laminar flow through the lymph vessels assumed, the shear rate (SR) at the inner surface of the vessel wall was calculated from SRϭ4f/(r 3 ), where f is the total flow volume and r is the internal radius of the lymph vessel [16] . The internal radius of the lymph vessels was measured by a vernier caliper when they were removed from the animal. Thus the wall shear stress (dyn/cm 2 ) was calculated by a formula: shear stressϭ1.4ϫ4f/(r 3 ); the viscosity of Krebs-bicarbonate solution is assumed to be 1.4 cP.
RESULTS

Flow-and ACh-induced responses of the bioassay arterial rings
The effluent through the pressurized canine thoracic duct caused a flow-dependent reduction of the basal tone of the arterial bioassay ring precontracted with U46619 (Fig. 1A) . Thus the stimulation of 0.5 and 2.0 ml/min at the flow rates produced ϳ19 and ϳ40% of the SNP-induced maximal relaxations of the arterial bioassay rings, respectively (Fig. 1A) . The addition of 10 Ϫ5 M ACh into the lymph vessel segment perfused at a constant flow rate of 0.5 ml/min caused an augmented relaxation (ϳ50%) of the arterial bioassay ring (Fig. 1A) . The data are summarized in Fig. 2 (flow rate 0.5 ml/min, 17.9Ϯ1.6%; 1.0 ml/min, 22.3Ϯ 0.8%; 2.0 ml/min, 38.9Ϯ5.7%; 0.5 ml/minϩACh 10 Ϫ5 M, 43.4Ϯ0.6%, nϭ3). In contrast, during the perfusion through the pressurized lymph vessel segments without intact endothelium, neither an increase of the inflow rate ranging from 0.5 to 2.0 ml/min nor an administration of 10 Ϫ5 M ACh caused a significant effect on U46619-induced contractions of the arterial bioassay rings. In the same bioassay ring, 10 Ϫ5 M SNP produced a marked relaxation (Fig. 1B) . No flow-or ACh (10 Ϫ5 M)-induced relaxations of the bioassay rings were observed during the perfusion through the stainless-steel tube (nϭ4).
The effects of L-NAME, L-NAME؉L-arginine, or indomethacin on the flow-and ACh-induced responses Figure 3 shows representative recordings of the effects of 5ϫ10 the presence of 0.5 ml/min at the flow rate produced a marked relaxation of the arterial bioassay ring (Fig.  3A) . The flow-and ACh-induced relaxations were markedly reduced after the lymphatic endothelial cells were pretreated with 5ϫ10 Ϫ5 M L-NAME (Fig. 3A) . The L-NAME-induced reduction of the ACh-induced relaxation in the same arterial bioassay ring was reversed by an additional treatment with 10 Ϫ3 M L-arginine (Fig. 3B) . In contrast, another treatment with 10 Ϫ3 M L-arginine in the presence of 5ϫ10 Ϫ5 M L-NAME produced no significant effect on the 1.0 ml/min flow rate only-mediated relaxation of the arterial bioassay rings (Fig. 3A, B) . As shown in Fig. 4A , the 1.0 ml/min flow-rate-induced relaxation of the arterial bioassay rings was significantly reduced by pretreatment with 5ϫ10
Ϫ5 M L-NAME [1.0 ml/min flow rate 23.2Ϯ2.2% (nϭ4) in the control vs. 5.8Ϯ0.5% (nϭ6) with L-NAME, pϽ0.01].
Simultaneous treatment with 5ϫ10
Ϫ5 M L-NAME and 10 Ϫ3 M L-arginine produced no significant effect on the flow-induced relaxation [1.0 ml/min flow rate 5.8Ϯ0.5% (nϭ6) with L-NAME vs. 6.3Ϯ0.6% (nϭ6) with L-NAMEϩL-arginine, not significant].
In contrast, ACh (10 Ϫ5 M)-induced relaxation of the arterial bioassay rings was significantly reduced by 5ϫ10 Ϫ5 M L-NAME [10 Ϫ5 M ACh 36.3Ϯ4.4% (nϭ4) in the control vs. 9.2Ϯ1.6% (nϭ6) with L-NAME, pϽ0.01]. The L-NAME-induced reduction of the ACh-mediated relaxation was significantly reversed by an additional treatment with 10 Ϫ3 M L-arginine [10 Ϫ5 M ACh 9.2Ϯ1.6% (nϭ6) with L-NAME vs. 27.0Ϯ2.3% (nϭ6) with L-NAMEϩL-arginine, pϽ0.01].
Pretreatment with 10
Ϫ5 M indomethacin produced no significant effect on the flow (1.0 ml/min)-and on the ACh (10 Ϫ5 M)-induced relaxations of the arterial bioassay rings superfused by the effluent passing through the lymphatic endothelial cells (nϭ4). nine caused a significant reduction of the flow-induced relaxation of the arterial bioassay ring, but it had no significant effect on the ACh-induced relaxation (Fig. 5) . The data are summarized in Table 1 . 3) were used to calculate the relationship between the extent of flow-induced relaxation and shear stress in the pressurized lymph vessel segments with intact endothelial cells. Figure 6 shows the relationship. The abscissa denotes shear stress calculated from 1.4ϫ4f/(r 3 ) using flow volume ( f ) and inner radius (r) of the lymph vessel segments. The ordinate demonstrates the extent of the product of flow-induced relaxation, normalized by using SNP-mediated maximal relaxation and the flow volume, which may indicate the amount of vasodilating substance(s) released from lymphatic endothelial cells over a constant time. If the flow-induced relaxation was proportional to the concentration of relaxing factor(s) released from the endothelial cells, the unit of the relaxation may be expressed as mg/ml; thus the unit of product of the relaxation and flow volume is given as (milligrams per milliliter) times (milliliters per minute) (ϭmg/min), suggesting the amount of relaxing factor(s) released over a constant time. The parameter has been accepted to demonstrate the amount of vasodilating substances released from endothelial cells in this cascade preparation [12] . The extent of flow-induced relaxation was directly proportional to shear stress on the endothelial cells of the pressurized lymph vessel segments.
Effects of L-
DISCUSSION
This study may be the first demonstration of flow-induced production and release of NO from the lymphatic endothelial cells of canine thoracic ducts. We therefore focused on demonstrating clearly the flowinduced production and release of endogenous NO from the lymphatic endothelial cells. The flow-mediated relaxation of conventional cascade arterial rings was abolished by a mechanical removal of the lymphatic endothelial cells in the pressurized thoracic ducts. This finding suggests that the stimulation of flow caused release of endothelium-derived relaxing factor(s) from lymphatic endothelial cells. It is compatible with our previous studies that ACh has produced a marked relaxation of canine thoracic ducts precontracted with norepinephrine via an activation of high-affinity muscarinic receptors on the lymphatic endothelial cells [10] , and that endothelial constitutive NO synthase (ecNOS)-immunoreactivity is clearly demonstrated in the cultured lymphatic endothelial cells isolated from canine thoracic ducts [19] .
In the present experiments, pretreatment with indomethacin (10 Ϫ5 M), an inhibitor of cyclooxygenase, did not affect the flow-induced relaxation of bioassay arterial rings, suggesting that prostacyclin and the other vasodilative prostaglandins played no important role in the flow-induced release of endothelium-derived relaxing factor(s). On the other hand, L-NAME, an inhibitor of NO biosynthesis, completely suppressed the flow-induced relaxation of the bioassay arterial rings. The finding may suggest that the flow-induced relaxation is mainly mediated through the production and release of endogenous NO or its related compounds from the lymphatic endothelial cells of the perfused thoracic duct, and this subsequently results in a marked relaxation of the arterial bioassay rings. These findings may therefore be a clear demonstration of the flow-dependent production and release of NO from lymphatic endothelial cells of larger trunk lymph vessels.
The linear relationship between the normalized amount of NO release from the lymphatic endothelial cells during a constant time and calculated shear stress was obtained by using the canine thoracic ducts (Fig. 6) . The amount of NO or its related compounds released from lymphatic endothelial cells seems to be proportional to an increase in shear stress up to 1.81 dyn/cm 2 loaded on the endothelial cells in the thoracic ducts. Compared with our data obtained with arterial and venous endothelial cells [12] , it may be a characteristic feature of the lymphatic endothelial cells that they exhibit the lowest sensitivity to changes (Fig. 6) . Further investigation will be needed to measure biochemically the amounts of NO or its metabolites, depending on changes in shear stress on the lymphatic endothelial cells. Another important aspect of the present study is that 10 Ϫ3 M L-arginine by itself in the absence of L-NAME causes a significant inhibition of flow-induced vasodilation of bioassay arterial rings. Moreover, the L-NAME-induced reduction of the ACh-induced relaxation was reversed by an additional treatment with 10 Ϫ3 M L-arginine (Fig. 3) , but not in the L-NAME-induced reduction of flow-induced relaxation (Fig. 3B) . The findings may be related to evidence of different mechanisms of intracellular transduction between agonist-and flow-induced production and the release of endogenous NO in the lymphatic endothelial cells. Similar findings have been obtained with canine carotid arteries and external jugular veins [12] and with rat mesenteric lymph vessels [17] . Several studies have also demonstrated that marked differences exist in the activation of the potassium channels, in the release of calcium ions from intracellular store sites, and in the intracellular alkalization between agonist-and flow-induced endothelium-dependent, and, NO-mediated vasodilation of blood vessels [20] . If high concentrations of L-arginine have an antagonistic effect [21] on one of these mechanisms that contribute mainly to flow-induced vasodilation in the present experiments, it may be reasonable that the pretreatment with L-arginine selectively reduced the flow-induced vasodilation of the arterial bioassay rings. The mode of action of high concentrations of Larginine, however, remains to be clarified.
